Mini review: Immune response to myelin-derived sulfatide and CNS-demyelination

Neurochemical Research

Volumn 32, Issue 2, 2007, Pages 257-262

  Halder, Ramesh C ^a   Jahng, A ^a   Maricic, I ^a   Kumar, Vipin ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

CD1; Central nervous system; Demyelination; EAE; Glycolipids; Microglia; Multiple sclerosis; Myelin; Sulfatide

Indexed keywords

CD1 ANTIGEN; CD1D ANTIGEN; GLYCOLIPID; MYELIN PROTEIN; SULFATIDE; TETRAMER;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; DEMYELINATION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; MACROPHAGE; MEDICAL LITERATURE; MICROGLIA; MULTIPLE SCLEROSIS; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; RESTRICTION MAPPING; SHORT SURVEY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD1; DEMYELINATING AUTOIMMUNE DISEASES, CNS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GALACTOSYLCERAMIDES; GLYCOLIPIDS; HUMANS; KILLER CELLS, NATURAL; MICE; MULTIPLE SCLEROSIS; SULFOGLYCOSPHINGOLIPIDS; T-LYMPHOCYTES;

EID: 33846918694     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9145-4     Document Type: Short Survey

References (37)

1. Uhlig H, Dernick R (1989) Monoclonal autoantibodies derived from multiple sclerosis patients and control persons and their reactivities with antigens of the central nervous system. Autoimmunity 5:87-99
2. Stevens A, Weller M, Wietholter H (1992) CSF and serum ganglioside antibody patterns in MS. Acta Neurol Scand 86:485-489
3. Bansal AS, Abdul-Karim B, Malik RA, Goulding P, Pumphrey RS, Boulton AJ, Holt PL, Wilson PB (1994) IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls. J Clin Pathol 47:300-302
4. Endo T, Deborah D, Scott S, Scott ST, Samar KK, Donald MM (1984) Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol 132:1793-1797
5. Ilvas AA, Chen ZW, Cook SD (2003) Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol 139:76-80
6. Steinman L (1996) Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299-302
7. Prat A, Antel J (2005) Pathogenesis of multiple sclerosis. Curr Opin Neurol 18:225-230
8. Sospedra M, Martin R (2005) Immunology of multiple sclerosis*. Annu Rev Immunol 23:683-747
9. Paterson PY (1980) Autoimmune diseases of myelin. Prog Clin Biol Res 49:19-36
10. Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-458
11. Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y, Kumar V (2001) Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med 194:1789-1799
12. Jahng A, Maricic I, Aguilera C, Cardell S, Halder RC, Kumar V (2004) Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med 199:947-957
13. Kumar V (2004) Homeostatic control of immunity by TCR peptide-specific Tregs. J Clin Invest 114:1222-1226
14. Sela BA, Konat G, Offner H (1982) Elevated ganglioside concentration in serum and peripheral blood lymphocytes from multiple sclerosis patients in remission. J Neurol Sci 54:143-148
15. Lubetzki C, Thuillier Y, Galli A, Lyon-Caen O, Lhermitte F, Zalc B (1989) Galactosylceramide: a reliable serum index of demyelination in multiple sclerosis. Ann Neurol 26:407-409
16. Kanter JL, Narayana S, Ho PP, Catz I, Warren KG, Sobel RA, Steinman L, Robinson WH (2006) Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12:138-143
17. Shamshiev A, Donda A, Carena I, Mori L, Kappos L, De Libero G (1999) Self glycolipids as T-cell autoantigens. Eur J Immunol 29:1667-1675
18. Shamshiev A, Donda A, Prigozy TI, Mori L, Chigorno V, Benedict CA, Kappos L, Sonnino S, Kronenberg M, De Libero G (2000) The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity 13:255-264
19. Battistini L, Fischer FR, Raine CS, Brosnan CF (1996) CD1b is expressed in multiple sclerosis lesions. J Neuroimmunol 67:145-151
20. Porcelli SA, Modlin RL (1999) The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 17:297-329
21. Brigl M, Brenner MB (2004) CD1: antigen presentation and T cell function. Annu Rev Immunol 22:817-890
22. Moody DB, Zajonc DM, Wilson IA (2005) Anatomy of CD1-lipid antigen complexes. Nat Rev Immunol 5:387-399
23. Bendelac A, Rivera MN, Park SH, Roark JH (1997) Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 15:535-562
24. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C III, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525-529
25. Zajonc DM, Maricic I, Wu D, Halder R, Roy K, Wong CH, Kumar V, Wilson IA (2005) Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med 202:1517-1526
26. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M (2000) Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 192:741-754
27. Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, YamamuraT (2000) Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 164:4375-4381
28. Becher B, Prat A, Antel JP (2000) Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia 29:293-304
29. Aloisi F (2001) Immune function of microglia. Glia 36:165-179
30. Carson MJ (2002) Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia 40:218-231
31. Hickey WF, Kimura H (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290-292
32. Byram SC, Carson MJ, DeBoy CA, Serpe CJ, Sanders VM, Jones KJ (2004) CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J Neurosci 24:4333-4339
33. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314-1318
34. Sedgwick JD, Schwender S, Gregersen R, Dorries R, ter Meulen V (1993) Resident macrophages (ramified microglia) of the adult brown Norway rat central nervous system are constitutively major histocompatibility complex class II positive. J Exp Med 177:1145-1152
35. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M, Lobell A, Khademi M, Borjesson O, Lindgren CM, Lundman P, Brookes AJ, Kere J, Luthman H, Alfredsson L, Hillert J, Klareskog L, Hamsten A, Piehl F, Olsson T (2005) MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 37:486-494
36. Youssef S, Stuve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS (2002) The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420:78-84
37. Lovett-Racke AE, Hussain RZ, Northrop S, Choy J, Rocchini A, Matthes L, Chavis JA, Diab A, Drew PD, Racke MK (2004) Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J Immunol 172:5790-5798